Is coronary revascularization the optimum strategy for patients with non-Q-wave myocardial infarction? A point-counterpoint

Clinical Cardiology

Volumn 21, Issue 12 SUPPL. 2, 1998, Pages

  Gersh, Bernard J ^a   O'Rourke, Robert A ^b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; PATHOPHYSIOLOGY; Q WAVE; TREATMENT INDICATION;

HEART CONDUCTION SYSTEM; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS;

EID: 3743117300     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (17)

1. DeWood MA, Stifter WF, Simpson CS, Spores J, Eugster GS, Judge TP, Hinnen ML: Coronary angiographic findings soon after non-Q-wave myocardial infarction. N Engl J Med 1986;315(7): 417-123
2. Gibson RS, Beller GA, Gheorghiade M, Nygaard TW, Watson DD, Huey BL, Syre SL, Kaiser DL: The prevalence and clinical significance of residual myocardial ischemia 2 weeks after uncomplicated non-Q wave infarction: A prospective natural history study. Circulation 1986;73(6):1186-1198
3. Davies RF, Goldberg AD, Forman S, Pepine CJ, Knatterud GL, Geller N, Sopko G, Pratt C, Deanfield J, Conti R: Asympomatic cardiac ischemia pilot (ACIP) study of two-year follow-up. Outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation 1997;95(8):2037-2043
4. Hutter AM, DeSanctis RW, Flynn T, Yeatman LA: Nontransmural myocardial infarction: A comparison of hospital and late clinical course of patients with that of matched patients with transmural anterior and transmural inferior myocardial infarction. Am J Cardiol 1981;48:595-602
5. Schectman KB, Capone RJ, Kleiger RE, Gibson RS, Schwartz DJ, Roberts R, Young PM, Boden WE: Risk stratification of patients with non-Q wave myocardial infarction. Circulation 1989;80(5): 1148-1158
6. Williams DO, Braunwald E, Thompson B, Sharaf BL, Buller CE, Knatterud GL: Results of percutaneous transluminal coronary angioplasty in unstable angina and non-Q-wave myocardial infarction. Circulation 1996;94(11):2749-2755
7. Stone PH, Thompson B, Anderson V, Kronenberg MW, Gibson RS, Rogers NJ, Diver DJ, Théroux P, Warnica JW, Nasmith JB, Kells C, Kleiman N, McCabe CH, Schactman M, Knatterud GL, Braunwald E: Influence of race, sex, and age on management of unstable angina and non-Q wave myocardial infarction. J Am Med Assoc 1996;275(14):1104-1112
8. Cannon CP, McCabe CH, Stone PH, Rogers WJ, Schactman M, Thompson BW, Pearce DJ, Diver DJ, Kells C, Feldman T, Williams M, Gibson RS, Kronenberg MW, Ganz LI, Anderson HV, Braunwald E: The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: Results of the TIMI III registry ECG ancillary study. J Am Coll Cardiol 1997;30(1):133-140
9. The TIMI Study Group: Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB trial. thrombolysis in myocardial ischemia. Circulation 1994;89(10):1545-1556
10. Anderson HV, Cannon CP, Stone PH, Williams DO: One-year results of the thrombolysis in myocardial infarction (TIMI) IIIb clinical trial. J Am Coll Cardiol 1995;26(7):1643-1650
11. Ferry DR, O'Rourke, Blaustein AS, Crawford MH, Deedwania PC, Carson PE, Pepine CJ, Thomas RG, Hlatky MA, Leppo JA, Iwane MK, Kleiger RE, Zoble RG, Dai H, Chow BK, Lavori PW, Boden WE: Design and baseline characteristics of the veterans affairs non-Q-wave infarction strategies in-hospital (VANQWISH) trial. VANQWISH trial research investigators. J Am Coll Cardiol 1998;31(2):312-320
12. Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel BJ, Russell RO, Smith EE III, Weaver WD: ACC/AHA guidelines for the management of patients with acute myocardial infarction. J Am Coll Cardiol 1996;28(5):1328-1419
13. The TIMI Study Group: Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) phase II trial. N Engl J Med 1989; 320:618-627
14. Terrin ML, Williams DO, Kleinman NS, Willerson J, Mueller HS, Desvigne-Nickens P, Forman SA, Knatterud GL, Braunwald E: Two-and three-year results of the thrombolysis in myocardial infarction (TIMI) phase II clinical trial. J Am Coll Cardiol 1993; 22(7):1763-1772
15. Stone PH, Raabe DS, Jaffe AS, Gustafson N, Muller JE, Turi ZG, Rutherford JD, Poole WK, Passamani E, Willerson JT, Sobel BE, Robertson T, Braunwald E: Prognostic significance of location and type of myocardial infarction: Independent adverse outcome associated with anterior location. J Am Coll Cardiol 1988;11(3): 453-163
16. Boden WE, O'Rourke RA, Crawford MH, Blaustein AS, Deedwania PC, Zoble RG, Wexler LF, Kleiger RE, Pepine CJ, Ferry DR, Chow BK, Lavori RW: Outcomes in patients with acute non-Q wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. N Engl J Med 1998;338(25):1785-1792
17. Lange RA, Hillis LD: Use and overuse of angiography and revascularization for acute coronary syndromes. N Engl J Med 1998; 338(25):1838-1839